Wirsching, H. -., Tabatabai, G., Roelcke, U., Hottinger, A. F., Jörger, F., Schmid, A., Plasswilm, L., Schrimpf, D., Mancao, C., Capper, D., Conen, K., Hundsberger, T., Caparrotti, F., von Moos, R., Riklin, C., Felsberg, J., Roth, P., Jones, D. T. W., Pfister, S., Rushing, E. J., Abrey, L., Reifenberger, G., Held, L., von Deimling, A., Ochsenbein, A., & Weller, M. (2018). bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Annals of oncology, 29, 1423–1430. http://access.bl.uk/ark:/81055/vdc_100095201172.0x00003d